Last quarter (Q3 2019), OWC Pharmaceutical Research's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, OWC Pharmaceutical Research's net income was $-287.00K. See OWC Pharmaceutical Research’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 18
Dec 17
Total Revenue
$ 0.00
$ 0.00
Gross Profit
-
-
Operating Expenses
$ 4.30M
$ 4.55M
Depreciation and Amortization
$ 7.00K
$ 8.34K
EBITDA
$ -3.56M
$ -4.55M
Operating Income
$ -4.30M
$ -4.55M
Other Income/Expenses
$ -6.69M
$ -5.00K
Pretax Income
$ -10.26M
$ -4.56M
Net Income
$ -10.26M
$ -4.56M
Per Share Metrics
Basic EPS
$ -0.07
$ -0.03
Diluted EPS
$ -0.07
$ -0.03
Weighted Average Shares Outstanding
148.07M
145.20M
Weighted Average Shares Outstanding (Diluted)
148.07M
145.20M
Currency in USD
OWC Pharmaceutical Research Earnings and Revenue History